Albatroz Therapeutics

Press Releases

09/04/2024

Albatroz Therapeutics Soars into Johnson & Johnson Innovation – JLABS Singapore

04/25/2023

Albatroz Therapeutics Secure $3 Million to Develop First-ever Therapy Blocking a Universal Process Involved in the Growth and Spread of Cancerous Solid Tumors and Arthritic Cartilage Degradation

03/19/2023

Amgen and NSG Biolabs Announce Albatroz Therapeutics as Winner of First Amgen Golden Ticket in Singapore